150 related articles for article (PubMed ID: 22480418)
1. Long-term activation of semicarbazide-sensitive amine oxidase lowers circulating levels of uric acid in diabetic conditions.
Carpéné C; Desquesnes A; Gomez-Ruiz A; Iffiú-Soltész Z; Le Gonidec S; Mercader J
Physiol Res; 2012; 61(3):251-7. PubMed ID: 22480418
[TBL] [Abstract][Full Text] [Related]
2. Benzylamine antihyperglycemic effect is abolished by AOC3 gene invalidation in mice but not rescued by semicarbazide-sensitive amine oxidase expression under the control of aP2 promoter.
Grès S; Bour S; Valet P; Carpéné C
J Physiol Biochem; 2012 Dec; 68(4):651-62. PubMed ID: 22547093
[TBL] [Abstract][Full Text] [Related]
3. Oral Supplementation with Benzylamine Delays the Onset of Diabetes in Obese and Diabetic db-/- Mice.
Iffiú-Soltesz Z; Wanecq E; Tóthfalusi L; Szökő É; Carpéné C
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444782
[TBL] [Abstract][Full Text] [Related]
4. Methylamine but not mafenide mimics insulin-like activity of the semicarbazide-sensitive amine oxidase-substrate benzylamine on glucose tolerance and on human adipocyte metabolism.
Iglesias-Osma MC; Bour S; Garcia-Barrado MJ; Visentin V; Pastor MF; Testar X; Marti L; Enrique-Tarancon G; Valet P; Moratinos J; Carpéné C
Pharmacol Res; 2005 Dec; 52(6):475-84. PubMed ID: 16135411
[TBL] [Abstract][Full Text] [Related]
5. Increased primary amine oxidase expression and activity in white adipose tissue of obese and diabetic db-/- mice.
Iffiú-Soltész Z; Mercader J; Daviaud D; Boucher J; Carpéné C
J Neural Transm (Vienna); 2011 Jul; 118(7):1071-7. PubMed ID: 21298297
[TBL] [Abstract][Full Text] [Related]
6. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats.
Abella A; Marti L; Camps M; Claret M; Fernández-Alvarez J; Gomis R; Gumà A; Viguerie N; Carpéné C; Palacín M; Testar X; Zorzano A
Diabetes; 2003 Apr; 52(4):1004-13. PubMed ID: 12663473
[TBL] [Abstract][Full Text] [Related]
7. Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice.
Iffiú-Soltész Z; Wanecq E; Lomba A; Portillo MP; Pellati F; Szöko E; Bour S; Woodley J; Milagro FI; Alfredo Martinez J; Valet P; Carpéné C
Pharmacol Res; 2010 Apr; 61(4):355-63. PubMed ID: 20045461
[TBL] [Abstract][Full Text] [Related]
8. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
[TBL] [Abstract][Full Text] [Related]
9. Semicarbazide-sensitive amine oxidase substrates fail to induce insulin-like effects in fat cells from AOC3 knockout mice.
Bour S; Prévot D; Guigné C; Stolen C; Jalkanen S; Valet P; Carpéné C
J Neural Transm (Vienna); 2007; 114(6):829-33. PubMed ID: 17406965
[TBL] [Abstract][Full Text] [Related]
10. Histamine oxidation in mouse adipose tissue is controlled by the AOC3 gene-encoded amine oxidase.
Iffiú-Soltész Z; Wanecq E; Prévot D; Grès S; Carpéné C
Inflamm Res; 2010 Mar; 59 Suppl 2():S227-9. PubMed ID: 20012150
[TBL] [Abstract][Full Text] [Related]
11. Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells.
Enrique-Tarancón G; Castan I; Morin N; Marti L; Abella A; Camps M; Casamitjana R; Palacín M; Testar X; Degerman E; Carpéné C; Zorzano A
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):171-80. PubMed ID: 10926841
[TBL] [Abstract][Full Text] [Related]
12. Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes.
Morin N; Lizcano JM; Fontana E; Marti L; Smih F; Rouet P; Prévot D; Zorzano A; Unzeta M; Carpéné C
J Pharmacol Exp Ther; 2001 May; 297(2):563-72. PubMed ID: 11303044
[TBL] [Abstract][Full Text] [Related]
13. Studies on the insulinomimetic effects of benzylamine, exogenous substrate of semicarbazide-sensitive amine oxidase enzyme in streptozotocin induced diabetic rats.
Soltész Z; Tábi T; Halász AS; Pálfi M; Kocsis E; Magyar K; Tóth M; Szökö E
J Neural Transm (Vienna); 2007; 114(6):851-5. PubMed ID: 17431735
[TBL] [Abstract][Full Text] [Related]
14. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 deficiency reduces leukocyte infiltration into adipose tissue and favors fat deposition.
Bour S; Caspar-Bauguil S; Iffiú-Soltész Z; Nibbelink M; Cousin B; Miiluniemi M; Salmi M; Stolen C; Jalkanen S; Casteilla L; Pénicaud L; Valet P; Carpéné C
Am J Pathol; 2009 Mar; 174(3):1075-83. PubMed ID: 19218346
[TBL] [Abstract][Full Text] [Related]
15. Prolonged treatment with aminoguanidine strongly inhibits adipocyte semicarbazide-sensitive amine oxidase and slightly reduces fat deposition in obese Zucker rats.
Prévot D; Soltesz Z; Abello V; Wanecq E; Valet P; Unzeta M; Carpéné C
Pharmacol Res; 2007 Jul; 56(1):70-9. PubMed ID: 17548204
[TBL] [Abstract][Full Text] [Related]
16. Benzylamine and methylamine, substrates of semicarbazide-sensitive amine oxidase, attenuate inflammatory response induced by lipopolysaccharide.
Lin Z; Li H; Luo H; Zhang Y; Luo W
Int Immunopharmacol; 2011 Aug; 11(8):1079-89. PubMed ID: 21414430
[TBL] [Abstract][Full Text] [Related]
17. New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
Yraola F; García-Vicente S; Fernandez-Recio J; Albericio F; Zorzano A; Marti L; Royo M
J Med Chem; 2006 Oct; 49(21):6197-208. PubMed ID: 17034126
[TBL] [Abstract][Full Text] [Related]
18. Obesity of mice lacking VAP-1/SSAO by Aoc3 gene deletion is reproduced in mice expressing a mutated vascular adhesion protein-1 (VAP-1) devoid of amine oxidase activity.
Jargaud V; Bour S; Tercé F; Collet X; Valet P; Bouloumié A; Guillemot JC; Mauriège P; Jalkanen S; Stolen C; Salmi M; Smith DJ; Carpéné C
J Physiol Biochem; 2021 Feb; 77(1):141-154. PubMed ID: 32712883
[TBL] [Abstract][Full Text] [Related]
19. Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice.
Yu PH; Wang M; Fan H; Deng Y; Gubisne-Haberle D
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E634-41. PubMed ID: 14656718
[TBL] [Abstract][Full Text] [Related]
20. Semicarbazide-sensitive amine oxidase in transgenic mice with diabetes.
Gokturk C; Nordquist J; Sugimoto H; Forsberg-Nilsson K; Nilsson J; Oreland L
Biochem Biophys Res Commun; 2004 Dec; 325(3):1013-20. PubMed ID: 15541390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
